Gyurci John 4

What Happened John Gyurci, Vice President and Chief Accounting Officer of MiniMed Group, Inc. (MMED), was granted 15,322 restricted stock units (RSUs) on March 11, 2026. The grant was a conversion of previously held Medtronic awards into MMED RSUs as part of MMED’s separation from Medtronic. No per-share price or cash value is reported (price = N/A); these are time-vesting equity awards rather than an open-market purchase or sale.

Key Details

• Transaction date (reporting period): March 11, 2026; Form 4 filed March 13, 2026 (timely).
• Transaction type: Award/Grant (code A) — 15,322 MMED RSUs granted.
• Price/Value: N/A (conversion of prior Medtronic awards; no cash purchase).
• Vesting: The RSUs vest in three equal installments on Jan 26, 2027; Jan 26, 2028; and Jan 26, 2029.
• Conversion mechanics: The Medtronic awards were converted to MMED RSUs under the Employee Matters Agreement and based in part on average Medtronic and MMED closing prices around the separation dates.
• Plan: Grants made under the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP).
• Shares owned after the transaction: Not disclosed in the provided Form 4 details.
• Remarks: Grant resulted from MMED’s separation from Medtronic; these are time-vesting awards, not immediate stock ownership.

Context This filing reflects an equity award conversion tied to a corporate separation, not a purchase or sale. Converted RSUs typically do not represent immediately tradable shares — value and ownership crystallize as the units vest (and may be subject to withholding or other plan terms). Such awards are routine when companies spin off or separate and do not by themselves indicate insider buying or selling intent.